NO20082922L - Terapeutisk middel for keratokonjunktive lidelser - Google Patents

Terapeutisk middel for keratokonjunktive lidelser

Info

Publication number
NO20082922L
NO20082922L NO20082922A NO20082922A NO20082922L NO 20082922 L NO20082922 L NO 20082922L NO 20082922 A NO20082922 A NO 20082922A NO 20082922 A NO20082922 A NO 20082922A NO 20082922 L NO20082922 L NO 20082922L
Authority
NO
Norway
Prior art keywords
therapeutic agent
defect
corneal
eprosartan
salt
Prior art date
Application number
NO20082922A
Other languages
English (en)
Norwegian (no)
Inventor
Masatsugu Nakamura
Keiichi Shibagaki
Shin-Ichiro Hirai
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of NO20082922L publication Critical patent/NO20082922L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20082922A 2005-12-06 2008-06-25 Terapeutisk middel for keratokonjunktive lidelser NO20082922L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005351712 2005-12-06
PCT/JP2006/324324 WO2007066678A1 (ja) 2005-12-06 2006-12-06 角結膜障害治療剤

Publications (1)

Publication Number Publication Date
NO20082922L true NO20082922L (no) 2008-06-27

Family

ID=38122824

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082922A NO20082922L (no) 2005-12-06 2008-06-25 Terapeutisk middel for keratokonjunktive lidelser

Country Status (8)

Country Link
US (1) US20090270474A1 (de)
EP (1) EP1958949A4 (de)
KR (1) KR20080074128A (de)
CN (1) CN101312962A (de)
CA (1) CA2631231A1 (de)
NO (1) NO20082922L (de)
RU (1) RU2423127C2 (de)
WO (1) WO2007066678A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4412C1 (ro) * 2014-08-29 2016-11-30 Алёна ДУРНЯ Utilizare a acidului 4-({2-butil-5-[2-carboxi-2-(tiofen-2-ilmetil)et-1-en-1-il] -1H-imidazol-1-il}metil) benzoic pentru ameliorarea elasticităţii vasculare în profilaxia complicaţiilor de geneză hipertensivă

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
ES2154277T3 (es) * 1993-07-15 2001-04-01 Hoffmann La Roche Combinacion farmaceutica que contiene un inhibidor del sistema renina-angiotensina y un antagonista de endotelina.
JP3136352B2 (ja) * 1996-01-22 2001-02-19 参天製薬株式会社 角結膜疾患治療剤
JPH10218792A (ja) * 1997-02-12 1998-08-18 Santen Pharmaceut Co Ltd アンギオテンシン変換酵素阻害薬を有効成分とする涙液分泌促進および角結膜障害治療剤
BR0010084A (pt) * 1999-04-28 2002-01-15 Takeda Chemical Industries Ltd Composição farmacêutica, processos para prevenir, tratar ou inibir o desenvolvimento de retinopatia simples ou retinopatia proliferativa, e para aumentar potencial retiniano ou edema retiniano de mamìfero, e, uso de um composto
JP2001031636A (ja) * 1999-05-18 2001-02-06 Senju Pharmaceut Co Ltd α−ケトアミド誘導体およびその医薬用途
JP2001058958A (ja) * 1999-08-20 2001-03-06 Senju Pharmaceut Co Ltd 涙液分泌促進剤
US20030018044A1 (en) * 2000-02-18 2003-01-23 Peyman Gholam A. Treatment of ocular disease
FI114483B (fi) * 2001-02-20 2004-10-29 Jurilab Ltd Oy Menetelmä kohonneen verenpaineen riskin osoittamiseksi ja sen käytöt

Also Published As

Publication number Publication date
CN101312962A (zh) 2008-11-26
KR20080074128A (ko) 2008-08-12
CA2631231A1 (en) 2007-06-14
RU2423127C2 (ru) 2011-07-10
US20090270474A1 (en) 2009-10-29
WO2007066678A1 (ja) 2007-06-14
RU2008127378A (ru) 2010-01-20
EP1958949A4 (de) 2010-04-28
EP1958949A1 (de) 2008-08-20

Similar Documents

Publication Publication Date Title
NO20076398L (no) Preventivt eller terapeutisk middel for keratokonjunktive forstyrrelser
DK1679074T3 (da) Terapeutisk middel til keratoconjunktive forstyrrelser
NO20082673L (no) Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens
EA200601223A1 (ru) Производные сульфонамида для лечения заболеваний
PE20110598A1 (es) Inhibidores de las enzimas de proteina cinasa activadas por mitogeno p38
DK1924264T3 (da) Diaminopyrimidiner som p2x3- og p2x2/3-modulatorer
NO20076450L (no) Heterosykliske forbindelser som nikotinsyrereseptoragonister for behandling av dyslipidemi
PE20061366A1 (es) Compuestos y composiciones como inhibidores de quinasa de proteina
NO20083562L (no) Cannabinoidreseptormodulatorer
NO20076502L (no) Pyrrolopyridiner nyttige som inhibitorer av proteinkinase
PE20090244A1 (es) Inhibidores de la proteina activadora de la 5-lipoxigenasa (flap)
ECSP077985A (es) Inhibidores de proteina cinasa derivados de pirrol (2,3-b) piridina
NO20071549L (no) Nye benzofuserte heteroalrylsulfamidderivater, anvendelige som anti-krampemidler
NO20080629L (no) Tiazolderivater som AMPK-aktiverere
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
EA200601141A1 (ru) Сульфонамидные производные для лечения заболеваний
NO20076460L (no) Nye fluorenderivater, sammensetninger inneholdende nevnte derivater og anvendelse derav
NO20052512L (no) Purinforbindelser og anvendelse deav som kannabinoiode reseptorligander
EA201000145A1 (ru) Кристаллические формы 4-метил-n-[3-(4-метилимидазол-1-ил)-5-трифторметилфенил]-3-(4-пиридин-3-илпиримидин-2-иламино)бензамида
EA200901514A1 (ru) Новая сольватная и кристаллическая форма производных карбамоилциклогексана
NO20073574L (no) Triazolsubstituerte aminobenzofenonforbindelser
EA200900337A1 (ru) Сульфонамидные производные в качестве адренергических агонистов и мускариновых антагонистов
ATE553106T1 (de) Heteroarylpyrrolopyridinone als kinaseinhibitoren
NO20075815L (no) Formuleringer og metoder for behandling av amyloidose
NO20081014L (no) Sammensetninger

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application